DYSLIPIDEMIA IN ELDERLY PATIENTS WITH HYPERTENSION

Nguyễn Văn Tuấn1,, Hoàng Thị Cúc1
1 Vinh Medical University

Main Article Content

Abstract

Objectives: To survey the prevalence of dyslipidemia and the relationship between dyslipidemia and some clinical and subclinical indexs among the elderly patients with hypertension who were treated at 115 General Hospital - Nghe An. Methods: This was a cross-sectional study conducted on 150 the ederly patients with hypertension who were treated at 115 General Hospital - Nghe An. Results: (1) The prevalence of dyslipidemia among the elderly with hypertension was 88,0%; (2) There is the relation between dyslipidemia with: fatty liver status, BMI, waist circumference, duration of hypertension, alcohol abuse and physical inactivity; (3) No relationship has been found between dyslipidemia with: age group (≥ 70 years old compared to 60 - 69 years old), sex, family history of dyslipidemia. Conclusion: Dyslipidemia account for a very high proportion among the elderly patients with hypertension, especially in patients with other associated cardiovascular risk factors such as overweight, obesity, alcohol abuse and physical inactivity.

Article Details

References

1. Bộ Y tế (2015) , “Hướng dẫn chẩn đoán bệnh và điều trị bệnh nội tiết và chuyển hóa,” Nhà xuất bản Y học, tr. 255–275.
2. Ayoade O. G., Umoh I., Amadi C. (2020), “Dyslipidemia and Associated Risk Factors among Nigerians with Hypertension,” Dubai Med. J., vol. 3, no. 4, pp. 155–161.
3. Chobanian A. V et al (2003), “Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.,” Hypertens. (Dallas, Tex. 1979), vol. 42, no. 6, pp. 1206–1252.
4. Ericsson S., Eriksson M., Vitols S., Einarsson K., Berglund L., Angelin B. (1991), “Influence of age on the metabolism of plasma low density lipoproteins in healthy males,” J. Clin. Invest., vol. 87, no. 2, pp. 591–596.
5. Fakhrul Alam L. C. (2021), “Dyslipidemia Associated with Hypertension Increases the Risks for Coronary Heart Disease: A Case-Control Study in a tertiary level hospital in Bangladesh,” J. Med. Sci. Clin. Res., vol. 09.
6. Sanyal A. J. (2002), “AGA technical review on nonalcoholic fatty liver disease.,” Gastroenterology, vol. 123, no. 5, pp. 1705–1725.
7. Sharma U., Kishore J., Garg A., Anand T., Chakraborty M., Lali P. (2013), “Dyslipidemia and associated risk factors in a resettlement colony of Delhi.,” J. Clin. Lipidol., vol. 7, no. 6, pp. 653–660.
8. Spannella F., Giulietti F., Di Pentima C., Sarzani R. (2019), “Prevalence and Control of Dyslipidemia in Patients Referred for High Blood Pressure: The Disregarded ‘Double-Trouble’ Lipid Profile in Overweight/Obese,” Adv. Ther., vol. 36, no. 6, pp. 1426–143.
9. Wang X., Magkos F., Mittendorfer B. (2011), “Sex differences in lipid and lipoprotein metabolism: It’s not just about sex hormones,” J. Clin. Endocrinol. Metab., vol. 96, no. 4, pp. 885–893.